Form 8-K - Current report:
SEC Accession No. 0001213900-17-004938
Filing Date
2017-05-11
Accepted
2017-05-11 16:05:59
Documents
2
Period of Report
2017-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k051117_immucell.htm 8-K 19736
2 PRESS RELEASE OF IMMUCELL CORPORATION DATED MAY 11, 2017. f8k051117ex99i_immucell.htm EX-99.1 42371
  Complete submission text file 0001213900-17-004938.txt   63196
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 17834277
SIC: 2835 In Vitro & In Vivo Diagnostic Substances